Biogen Pharmachem Industries Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹0.81
- Today's High:
- ₹0.86
- Open Price:
- ₹0.82
- 52W Low:
- ₹0.53
- 52W High:
- ₹1.26
- Prev. Close:
- ₹0.82
- Volume:
- 4966628
Company Statistics
- Market Cap.:
- ₹169.68 million
- Book Value:
- Revenue TTM:
- ₹0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- ₹0
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
Biogen Pharmachem Industries Limited had its IPO on under the ticker symbol 531752.
The company operates in the Other sector and Other industry. Biogen Pharmachem Industries Limited has a staff strength of 0 employees.
Stock update
Shares of Biogen Pharmachem Industries Limited opened at ₹0.82 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹0.81 - ₹0.86, and closed at ₹0.84.
This is a +2.44% increase from the previous day's closing price.
A total volume of 4,966,628 shares were traded at the close of the day’s session.
In the last one week, shares of Biogen Pharmachem Industries Limited have increased by +9.09%.
Biogen Pharmachem Industries Limited's Key Ratios
Biogen Pharmachem Industries Limited has a market cap of ₹169.68 million, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Biogen Pharmachem Industries Limited’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures Biogen Pharmachem Industries Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Biogen Pharmachem Industries Limited’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q0.33333333333333, Biogen Pharmachem Industries Limited’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Biogen Pharmachem Industries Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Biogen Pharmachem Industries Limited’s profitability.
Biogen Pharmachem Industries Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Biogen Pharmachem Industries Limited stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹547.43 million
- Total Liabilities
- ₹1.54 million
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
Biogen Pharmachem Industries Limited ended 2024 with ₹547.43 million in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹547.43 million while shareholder equity stood at ₹545.90 million.
Biogen Pharmachem Industries Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹1.54 million in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹87000.00 and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.00.
Biogen Pharmachem Industries Limited’s total current assets stands at ₹1.45 million while long-term investments were ₹0 and short-term investments were ₹1.20 million. Its net receivables were ₹0.00 compared to accounts payable of ₹0.00 and inventory worth ₹0.00.
In 2024, Biogen Pharmachem Industries Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Biogen Pharmachem Industries Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹0.84
- 52-Week High
- ₹1.26
- 52-Week Low
- ₹0.53
- Analyst Target Price
- ₹
Biogen Pharmachem Industries Limited stock is currently trading at ₹0.84 per share. It touched a 52-week high of ₹1.26 and a 52-week low of ₹1.26. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹0.8 and 200-day moving average was ₹0.75 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Biogen Pharmachem Industries Limited
Similar Industry Stocks (Other)
Most Active
Top Gainers
Top Losers
About
Sun Techno Overseas Limited does not have significant operations. Previously it was engaged in trading shares, mutual funds, and other investments. The company was formerly known as Wellworth Overseas Limited and changed its name to Sun Techno Overseas Limited in August 2011. Sun Techno Overseas Limited was incorporated in 1995 and is based in Rajkot, India.